Polio endgame: Lessons for the global rotavirus vaccination program

Viral Infections, Non-HIV

Continued Evidence of the Impact of Rotavirus Vaccine in Children Less than 3 Years of Age from the US New Vaccine Surveillance Network- a Multi-Site Active Surveillance Program, 2006-2016

Clin Infect Dis.

Staat MA, Payne DC, Halasa N, Weinberg GA, Donauer S, Wikswo M, McNeal M, Edwards KM, Szilagyi PG, Bernstein DI, Curns AT, Sulemana I, Esona MD, Bowen MD, Parashar UD, and the New Vaccine Surveillance Network (NVSN).

doi: 10.1093/cid/ciaa150.

Viral Infections, Non-HIV

Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth

N Engl J Med.

Bines JE, At Thobari J, Satria CD, Handley A, Watts E, Cowley D, Nirwati H, Ackland J, Standish J, Justice F, Byars G, Lee KJ, Barnes GL, Bachtiar NS, Viska Icanervilia A, Boniface K, Bogdanovic-Sakran N, Pavlic D, Bishop RF, Kirkwood CD, Buttery JP, Soenarto Y

doi: 10.1056/NEJMoa1706804.

Further Publications Infectiology

Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trial

Vaccine

Zaman K, Kovacs SD, Vanderende K, Aziz A, Yunus M, Khan S, Snider CJ, An Q, Estivariz CF, Oberste MS, Pallansch MA, Anand A

doi: 10.1016/j.vaccine.2021.08.065

Viral Infections, Non-HIV

Risk of Rotavirus Nosocomial Spread After Inpatient Pentavalent Rotavirus Vaccination

Pediatrics.

Hofstetter AM, Lacombe K, Klein EJ, Jones C, Strelitz B, Jacobson E, Ranade D, Ward ML, Mijatovic-Rustempasic S, Evans D, Wikswo M, Bowen MD, Parashar UD, Payne DC, Englund JA

doi: 10.1542/peds.2017-1110.

Bacterial Infections

Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial

Vaccine

Abu-Elyazeed R, Klein NP, Moerman L, Povey M, Pruitt A, Senders S, Silas P, Bi D, Rota-090 Study Group.

doi: 10.1016/j.vaccine.2020.08.070

Further Publications Infectiology

Global Rotavirus and Pneumococcal Conjugate Vaccine Introductions and the Association With Country Disease Surveillance, 2006-2018

J Infect Dis

Peck ME, Hampton LM, Antoni S, Ogbuanu I, Serhan F, Nakamura T, Walldorf JA, Cohen AL

doi: 10.1093/infdis/jiab069

Viral Infections, Non-HIV

Post-vaccination serum anti-rotavirus immunoglobulin A as a correlate of protection against rotavirus gastroenteritis across settings

J Infect Dis.

Baker JM, Tate JE, Leon J, Haber MJ, Pitzer VE, Lopman BA

doi: 10.1093/infdis/jiaa068.

Viral Infections, Non-HIV

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials

Vaccine.

Whitworth HS, Gallagher KE, Howard N, Mounier-Jack S, Mbwanji G, Kreimer AR, Basu P, Kelly H, Drolet M, Brisson M, Watson-Jones D

doi: 10.1016/j.vaccine.2019.12.017.

Viral Infections, Non-HIV

Ensuring global access to COVID-19 vaccines

Lancet.

Yamey G, Schäferhoff M, Hatchett R, Pate M, Zhao F, McDade KK

doi: 10.1016/S0140-6736(20)30763-7.

Related content

Continued Evidence of the Impact of Rotavirus Vaccine in Children Less than 3 Years of Age from the US New Vaccine Surveillance Network- a Multi-Site Active Surveillance Program, 2006-2016

Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth

Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trial

Risk of Rotavirus Nosocomial Spread After Inpatient Pentavalent Rotavirus Vaccination

Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial

Global Rotavirus and Pneumococcal Conjugate Vaccine Introductions and the Association With Country Disease Surveillance, 2006-2018

Post-vaccination serum anti-rotavirus immunoglobulin A as a correlate of protection against rotavirus gastroenteritis across settings

Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials

Ensuring global access to COVID-19 vaccines